Study of a new medicine for obesity in healthy and overweight people
Part of Hormones & metabolism clinical trials.
This study tests a new medicine (NNC6022-0004) in healthy volunteers and people with obesity to check its safety. If you qualify, you may help see if this drug is safe for future use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male, or a female who cannot get pregnant (e.g., postmenopausal or surgically sterile).
- For most parts, you need to be 18 to 55 years old; for optional Part E, up to 65 years old.
- Your body mass index (BMI) must be between 18.5 and 29.9 for most parts, or between 30 and 45 if you join Part E (with some exceptions).
- You must weigh at least 50 kg (110 lbs).
- You must be generally healthy based on medical history and tests.
- You cannot have taken certain medications or vaccines within 2 weeks before screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This trial tests a new medicine, HM17321, to see how the body processes it. It is for healthy adults and adults with obesity who want to help find new treatment options.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.